Long-Term Outcomes in Patients with Tardive Dyskinesia who Were Early Responders with Valbenazine

被引：0
|
作者：
Factor, S.
Comella, C.
Marder, S.
Burke, J.
Farahmand, K.
Siegert, S.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1456
引用
收藏
页码：S595 / S596
页数：2
相关论文
共 50 条
  • [1] Treatment Responses with Long-Term Valbenazine in Patients with Tardive Dyskinesia
    Singer, Carlos
    Comella, Cynthia
    Marder, Stephen
    Farahmand, Khodayar
    Jimenez, Roland
    [J]. NEUROLOGY, 2020, 94 (15)
  • [2] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. ANNALS OF CLINICAL PSYCHIATRY, 2023, 35 (01) : 3 - 3
  • [3] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. CNS SPECTRUMS, 2023, 28 (02) : 241 - 241
  • [4] Long-term effects of valbenazine on tardive dyskinesia in patients with a mood disorder
    McIntyre, R.
    Nierenberg, A.
    Farahmand, K.
    Burke, J.
    Siegert, S.
    [J]. BIPOLAR DISORDERS, 2018, 20 : 116 - 116
  • [5] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farah-Mand, Khodayar
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 344 - 345
  • [6] Sustained Treatment Response with Long-Term Valbenazine in Patients with Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. NEUROLOGY, 2023, 100 (17)
  • [7] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farahmand, Khodayar
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 344 - 345
  • [8] Long-Term Outcomes with Valbenazine 40 mg/day in Adults with Tardive Dyskinesia
    Marder, S.
    Comella, C.
    Singer, C.
    Chepke, C.
    Burke, J.
    Farahmand, K.
    Siegert, S.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S598 - S598
  • [9] Effects of Concomitant Medication Use on Tardive Dyskinesia Outcomes in Long-Term Valbenazine Trials
    Comella, Cynthia
    Singer, Carlos
    Kane, John
    Farahmand, Khodayar
    Burke, Joshua
    Siegert, Scott
    [J]. NEUROLOGY, 2019, 92 (15)
  • [10] LONG-TERM COST-EFFECTIVENESS OF VALBENAZINE AND DEUTETRABENAZINE FOR TARDIVE DYSKINESIA
    Harrigan, K.
    Walton, S. M.
    Huang, S. P.
    Kumar, V. M.
    Chapman, R. H.
    Atlas, S. J.
    Agboola, F. O.
    Ollendorf, D. A.
    Touchette, D. R.
    [J]. VALUE IN HEALTH, 2018, 21 : S184 - S184
12345